IN8bio, Inc. (INAB)
NASDAQ: INAB · IEX Real-Time Price · USD
1.060
+0.020 (1.92%)
At close: Apr 24, 2024, 4:00 PM
1.010
-0.050 (-4.72%)
After-hours: Apr 24, 2024, 7:30 PM EDT

IN8bio Statistics

Total Valuation

IN8bio has a market cap or net worth of $45.88 million. The enterprise value is $29.50 million.

Market Cap 45.88M
Enterprise Value 29.50M

Important Dates

The next estimated earnings date is Friday, May 10, 2024, before market open.

Earnings Date May 10, 2024
Ex-Dividend Date n/a

Share Statistics

IN8bio has 43.29 million shares outstanding. The number of shares has increased by 42.43% in one year.

Shares Outstanding 43.29M
Shares Change (YoY) +42.43%
Shares Change (QoQ) +9.79%
Owned by Insiders (%) 15.97%
Owned by Institutions (%) 37.38%
Float 24.46M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.84
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.57, with a Debt / Equity ratio of 0.20.

Current Ratio 4.57
Quick Ratio n/a
Debt / Equity 0.20
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -147.70% and return on invested capital (ROIC) is -100.59%.

Return on Equity (ROE) -147.70%
Return on Assets (ROA) -105.00%
Return on Capital (ROIC) -100.59%
Revenue Per Employee n/a
Profits Per Employee -$967,968
Employee Count 31
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -64.67% in the last 52 weeks. The beta is -0.01, so IN8bio's price volatility has been lower than the market average.

Beta (1Y) -0.01
52-Week Price Change -64.67%
50-Day Moving Average 1.13
200-Day Moving Average 1.17
Relative Strength Index (RSI) 46.31
Average Volume (30 Days) 351,527

Short Selling Information

The latest short interest is 51,614, so 0.12% of the outstanding shares have been sold short.

Short Interest 51,614
Short Previous Month 84,747
Short % of Shares Out 0.12%
Short % of Float 0.21%
Short Ratio (days to cover) 0.27

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -30.01M
Pretax Income -30.01M
Net Income -30.01M
EBITDA -27.51M
EBIT -30.01M
Earnings Per Share (EPS) -$1.00
Full Income Statement

Balance Sheet

The company has $21.28 million in cash and $4.89 million in debt, giving a net cash position of $16.39 million or $0.38 per share.

Cash & Cash Equivalents 21.28M
Total Debt 4.89M
Net Cash 16.39M
Net Cash Per Share $0.38
Equity / Book Value 24.94M
Book Value Per Share 0.58
Working Capital 19.23M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$23.34 million and capital expenditures -$600,000, giving a free cash flow of -$23.94 million.

Operating Cash Flow -23.34M
Capital Expenditures -600,000
Free Cash Flow -23.94M
FCF Per Share -$0.80
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

IN8bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -42.43%
Shareholder Yield -42.43%
Earnings Yield -65.40%
FCF Yield -52.17%

Analyst Forecast

The average price target for IN8bio is $8.63, which is 714.15% higher than the current price. The consensus rating is "Strong Buy".

Price Target $8.63
Price Target Difference 714.15%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 3